Patient concerns regarding chronic hepatitis B and C infection
AbstractCounselling of patients with viral hepatitis is often limited to discussions about how the virus is transmitted. The aim of the present study was to document the principal concerns of patients suffering from chronic hepatitis B and C infection. The most common volunteered concerns were infecting family members [80.6%], infecting others [66.7%], side-effects of treatment [50.0%], disease progression to cirrhosis [44.4%], loss of employment [41.7%], liver transplantation [36.1%], social stigma [36.1%], change in lifestyle [33.3%], development of liver cancer [25%], costs and money [22.2%], fear of disease [5.6%] and psychological disease [5.6%]. Health care providers who focus counseling efforts exclusively on viral transmission are unlikely to address other important concerns
Alizadeh, A.H.M., Ranjbar, M. & Yadollahzadeh, M. (2008). Patient concerns regarding chronic hepatitis B and C infection. http://www.who.int/iris/handle/10665/117538
EMHJ - Eastern Mediterranean Health Journal, 14 (5), 1142-1147, 2008
MetadataShow full item record
Showing items related by title and MeSH subject.
Genotype characterization of occult hepatitis B virus strains among Egyptian chronic hepatitis C patients Kishk, R.; Aboul Atta, H.; Ragheb, M.; Kamel, M.; Metwally, L.; Nemr, N. (2014)Chronic hepatitis C virus [HCV]infection combined with occult hepatitis B virus [HBV]infection has been associated with increased risk of hepatitis, cirrhosis and hepatocellular carcinoma.This study aimed to determine the prevalence of occult HBV infection among Egyptian chronic HCV patients, the genotype and occurrence of surface gene mutations of HBV and the impact of co-infection on early response to treatment.The study enrolled 162 chronic HCV patients from Ismailia Fever Hospital, Egypt, who were HBV surface antigen-negative.All patients ...
John, A.K.; Al Kaabi, S.; John, A.; Singh, R.; Derbala, M. (2010)Hepatitis C virus [HCV] infection is a major public health problem in the Middle East. A database of 400 patients with chronic HCV in Qatar was retrospectively analysed: 242 patients underwent antiviral treatment, of whom 212 [87.6%] were naive to treatment. The response to treatment and the predictors of response were studied. The largest group of patients were of Egyptian origin. The rate of sustained virological response [SVR] varied significantly between patients with HCV genotypes 2 or 3 [79.6%] and genotype 1 [45.6%] and 4 [the predominant ...